Appotronics Corporation Limited (SHA:688007)

Sage Therapeutics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,435	2,419	2,213	2,541	2,498	1,949
Revenue Growth (YoY)	10.71%	9.27%	-12.90%	1.72%	28.19%	-1.53%
Cost of Revenue	1,836	1,797	1,494	1,760	1,684	1,403
Gross Profit	598.7	621.53	719.79	781.43	814.33	545.61
Selling, General & Admin	350.05	353.61	438.12	531.51	447.74	278.33
Research & Development	252.8	243.81	277.15	258.91	229.75	195.46
Other Operating Expenses	-5.56	-10.27	-5.35	-22.84	-1.15	0.68
Operating Expenses	601.04	595.91	709.55	774.42	681.4	483.86
Operating Income	-2.34	25.62	10.24	7.01	132.94	61.75
Interest Expense	-17.69	-18.36	-18.64	-24.82	-17.08	-20.07
Interest & Investment Income	11.43	29.05	34.87	21.69	50.28	28.27
Currency Exchange Gain (Loss)	0.91	0.91	6.62	18.64	-0.47	2.23
Other Non Operating Income (Expenses)	-4.97	-3.59	-8.06	-4.77	-3.37	-2.69
EBT Excluding Unusual Items	-12.67	33.63	25.03	17.74	162.3	69.49
Gain (Loss) on Sale of Investments	-50.79	-24.79	-11.48	-3.32	40.13	-
Gain (Loss) on Sale of Assets	-1.29	-2.01	-2.06	-0.97	1.44	0.28
Asset Writedown	-18.21	-10.18	-11.47	-1.21	-4	-1.39
Other Unusual Items	10.82	10.77	37.65	15.27	88.66	43.04
Pretax Income	-72.14	7.42	37.67	27.51	288.53	111.42
Income Tax Expense	-0.55	13.3	20.06	-3.33	66.99	24.76
Earnings From Continuing Operations	-71.59	-5.88	17.62	30.84	221.53	86.66
Minority Interest in Earnings	33.64	33.84	85.57	88.6	11.83	27.19
Net Income	-37.95	27.95	103.19	119.44	233.36	113.85
Net Income to Common	-37.95	27.95	103.19	119.44	233.36	113.85
Net Income Growth	-	-72.91%	-13.61%	-48.82%	104.98%	-38.94%
Shares Outstanding (Basic)	461	466	449	459	449	455
Shares Outstanding (Diluted)	461	466	469	459	458	455
Shares Change (YoY)	-1.13%	-0.67%	2.10%	0.40%	0.48%	9.90%
EPS (Basic)	-0.08	0.06	0.23	0.26	0.52	0.25
EPS (Diluted)	-0.08	0.06	0.22	0.26	0.51	0.25
EPS Growth	-	-72.73%	-15.38%	-49.02%	104.00%	-44.44%
Free Cash Flow	-15.9	-1.82	248.83	10.02	-64.68	-13.88
Free Cash Flow Per Share	-0.03	-0.00	0.53	0.02	-0.14	-0.03
Dividend Per Share	0.025	0.025	0.070	0.054	0.105	0.055
Dividend Growth	-64.21%	-64.21%	29.37%	-48.57%	90.91%	-26.67%
Gross Margin	24.59%	25.70%	32.52%	30.75%	32.60%	28.00%
Operating Margin	-0.10%	1.06%	0.46%	0.28%	5.32%	3.17%
Profit Margin	-1.56%	1.16%	4.66%	4.70%	9.34%	5.84%
Free Cash Flow Margin	-0.65%	-0.07%	11.24%	0.39%	-2.59%	-0.71%
EBITDA	174.96	198.63	166.05	133.67	246.05	168.36
EBITDA Margin	7.19%	8.21%	7.50%	5.26%	9.85%	8.64%
D&A For EBITDA	177.31	173.01	155.82	126.66	113.11	106.61
EBIT	-2.34	25.62	10.24	7.01	132.94	61.75
EBIT Margin	-0.10%	1.06%	0.46%	0.28%	5.32%	3.17%
Effective Tax Rate	-	179.34%	53.24%	-	23.22%	22.23%
Revenue as Reported	2,435	2,419	2,213	2,541	2,498	1,949
Advertising Expenses	-	2.72	3.79	-	-	-

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.